Literature DB >> 17826746

Multiple brain pathways and receptors underlying tobacco addiction.

Jed E Rose1.   

Abstract

Over the last 20 years much progress has been made in understanding the pharmacologic basis of tobacco addiction. In particular, the role of nicotine in reinforcing smoking behavior has been studied from a variety of perspectives. This article discusses two important aspects of this topic: (1) brain pathways underlying tobacco addiction; and (2) the actions of nicotine at nicotinic cholinergic receptors. Recent evidence will be reviewed indicating that nicotine reinforces smoking behavior by acting on more than one subtype of nicotinic receptor. Similarly, the role of several brain pathways in tobacco addiction will be considered. Tobacco addiction may thus be seen as a complex neuropsychopharmacological disorder; further progress in smoking cessation treatment may require that we address the multiple molecular and brain components of this addiction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826746     DOI: 10.1016/j.bcp.2007.07.039

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  28 in total

1.  Understanding of nicotinic acetylcholine receptors.

Authors:  Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

2.  Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype.

Authors:  Scott R Breining; Merouane Bencherif; Sharon R Grady; Paul Whiteaker; Michael J Marks; Charles R Wageman; Henry A Lester; Daniel Yohannes
Journal:  Bioorg Med Chem Lett       Date:  2009-05-27       Impact factor: 2.823

Review 3.  Modeling and simulation of ion channels.

Authors:  Christopher Maffeo; Swati Bhattacharya; Jejoong Yoo; David Wells; Aleksei Aksimentiev
Journal:  Chem Rev       Date:  2012-10-04       Impact factor: 60.622

4.  Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence.

Authors:  Lingjun Zuo; Yunlong Tan; Chiang-Shan R Li; Zhiren Wang; Kesheng Wang; Xiangyang Zhang; Xiandong Lin; Xiangning Chen; Chunlong Zhong; Xiaoping Wang; Jijun Wang; Lu Lu; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-07-30       Impact factor: 3.568

Review 5.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

Review 6.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

8.  The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.

Authors:  Eoin C O'Connor; Dale Parker; Hans Rollema; Andy N Mead
Journal:  Psychopharmacology (Berl)       Date:  2009-12-05       Impact factor: 4.530

Review 9.  Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.

Authors:  Matthias E Liechti; Athina Markou
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  The Sensory Impact of Nicotine on Noradrenergic and Dopaminergic Neurons of the Nicotine Reward - Addiction Neurocircuitry.

Authors:  Jed E Rose; Ozra Dehkordi; Kebreten F Manaye; Richard M Millis; Salman Ameri Cianaki; Annapurni Jayam-Trouth
Journal:  J Addict Res Ther       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.